Lexeo Therapeutics, Inc.
LXEO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001907108
In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Lexeo Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 141
- +5 vs. Q1 2026
- Shares held
- 88.2M
- +13.3M (+17.8%) vs. Q1 2026
- Total value
- $410.9M
- −$19.2M (−4.5%) vs. Q1 2026
- New holders
- 27
- 59 more added
- Sold out
- 22
- 39 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LXEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 141 | $410.9M |
| Q1 2026 | 139 | $458.7M |
| Q4 2025 | 146 | $759.2M |
| Q3 2025 | 109 | $327.5M |
| Q2 2025 | 90 | $169.9M |
| Q1 2025 | 88 | $100.0M |
| Q4 2024 | 90 | $194.2M |
| Q3 2024 | 69 | $268.8M |
| Q2 2024 | 60 | $426.3M |
| Q1 2024 | 54 | $361.5M |
| Q4 2023 | 31 | $217.1M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Lexeo Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 202,383 | $942.1K | 0.00% | +29,680+17.2% | Added |
| Renaissance Technologies LLC | 250,365 | $1.17M | 0.00% | +250,365 | New |
| AQR Capital Management LLC | 256,661 | $1.19M | 0.00% | −82,962−24.4% | Reduced |
| Hennion & Walsh Asset Management, Inc. | 265,697 | $1.24M | 0.04% | +265,697 | New |
| Squarepoint Ops LLC | 294,774 | $1.37M | 0.00% | −24,316−7.6% | Reduced |
| Trexquant Investment LP | 314,891 | $1.47M | 0.01% | +314,891 | New |
| UBS Group AG | 354,044 | $1.65M | 0.00% | +32,307+10.0% | Added |
| DAFNA Capital Management LLC | 377,059 | $1.76M | 0.33% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 388,398 | $1.81M | 0.00% | +160,197+70.2% | Added |
| Morgan Stanley | 395,102 | $1.84M | 0.00% | −7,822−1.9% | Reduced |
| Vanguard Fiduciary Trust Co | 430,696 | $2.00M | 0.00% | +45,962+11.9% | Added |
| Bank of America Corp | 490,331 | $2.28M | 0.00% | −1,201−0.2% | Reduced |
| Ikarian Capital, LLC | 513,011 | $2.39M | 0.39% | 00.0% | Unchanged |
| Vanguard Portfolio Management LLC | 613,826 | $2.86M | 0.00% | +36,634+6.3% | Added |
| Standard Life Aberdeen plc | 675,092 | $3.14M | 0.00% | +429,188+174.5% | Added |
| Northern Trust Corp | 867,391 | $4.04M | 0.00% | +373,725+75.7% | Added |
| Blackstone Group Inc. | 904,959 | $4.22M | 0.01% | 00.0% | Unchanged |
| Spruce Street Capital LP | 928,593 | $4.32M | 0.85% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 1,287,185 | $5.99M | 0.00% | +183,601+16.6% | Added |
| Nantahala Capital Management, LLC | 1,300,000 | $6.05M | 0.37% | +100,000+8.3% | Added |
| Qube Research & Technologies Ltd | 1,376,222 | $6.41M | 0.01% | +910,707+195.6% | Added |
| Avoro Capital Advisors LLC | 1,489,189 | $6.93M | 0.06% | −385,811−20.6% | Reduced |
| ADAR1 Capital Management, LLC | 1,565,950 | $7.29M | 0.34% | +98,600+6.7% | Added |
| Geode Capital Management, LLC | 1,747,959 | $8.14M | 0.00% | +234,182+15.5% | Added |
| 683 Capital Management, LLC | 1,875,000 | $8.73M | 0.80% | +675,000+56.3% | Added |
| Goldman Sachs Group Inc | 2,149,612 | $10.0M | 0.00% | +199,727+10.2% | Added |
| Balyasny Asset Management LLC | 2,412,742 | $11.2M | 0.02% | +823,157+51.8% | Added |
| Woodline Partners LP | 2,500,532 | $11.6M | 0.04% | −250,000−9.1% | Reduced |
| Millennium Management LLC | 2,833,622 | $13.2M | 0.01% | +1,220,842+75.7% | Added |
| Vanguard Capital Management LLC | 3,125,893 | $14.6M | 0.00% | +118,800+4.0% | Added |
| Citadel Advisors LLC | 3,898,570 | $18.1M | 0.01% | +63,571+1.7% | Added |
| OrbiMed Advisors LLC | 3,947,850 | $18.4M | 0.35% | +345,400+9.6% | Added |
| Jupiter Topco LLC | 3,954,691 | $18.4M | 0.01% | +3,954,691 | New |
| Paradigm Biocapital Advisors LP | 4,175,382 | $19.4M | 0.36% | −2,008,752−32.5% | Reduced |
| Vestal Point Capital, LP | 4,320,000 | $20.1M | 0.47% | −155,000−3.5% | Reduced |
| State Street Corp | 4,354,757 | $20.3M | 0.00% | +786,515+22.0% | Added |
| Frazier Life Sciences Management, L.P. | 4,824,725 | $22.5M | 0.49% | +400,000+9.0% | Added |
| Ra Capital Management, L.P. | 5,000,000 | $23.3M | 0.20% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,739,455 | $26.7M | 0.00% | +628,584+12.3% | Added |
| Affinity Asset Advisors, LLC | 5,807,611 | $27.0M | 1.32% | +757,400+15.0% | Added |
| Suvretta Capital Management, LLC | 6,384,200 | $29.7M | 0.62% | +5,134,200+410.7% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,680,449−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −1,100,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −181,676−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −142,571−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −47,988−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −47,964−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −46,998−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −34,269−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −34,297−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −26,119−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −24,221−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −12,683−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,901−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −11,132−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −1,456−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,240−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −411−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Basecamp Wealth Advisors LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |